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Abstract
The nuclear hormone receptor PPARb/d is integral to efficient wound re-epithelialization and implicated in epidermal
maturation. However, the mechanism underlying the latter process of epidermal differentiation remains unclear. We
showed that ligand-activated PPARb/d indirectly stimulated keratinocyte differentiation, requiring de novo gene
transcription and protein translation. Using organotypic skin cultures constructed from PPARb/d- and angiopoietin-like 4
(ANGPTL4)-knockdown human keratinocytes, we showed that the expression of ANGPTL4, a PPARb/d target gene, is
essential for the receptor mediated epidermal differentiation. The pro-differentiation effect of PPARb/d agonist GW501516
was also abolished when keratinocytes were co-treated with PPARb/d antagonist GSK0660 and similarly in organotypic skin
culture incubated with blocking ANGPTL4 monoclonal antibody targeted against the C-terminal fibrinogen-like domain. Our
focused real-time PCR gene expression analysis comparing the skin biopsies from wildtype and ANGPTL4-knockout mice
confirmed a consistent down-regulation of numerous genes involved in epidermal differentiation and proliferation in the
ANGPTL4-knockout skin. We further showed that the deficiency of ANGPTL4 in human keratinocytes and mice skin have
diminished expression of various protein kinase C isotypes and phosphorylated transcriptional factor activator protein-1,
which are well-established for their roles in keratinocyte differentiation. Chromatin immunoprecipitation confirmed that
ANGPTL4 stimulated the activation and binding of JUNB and c-JUN to the promoter region of human involucrin and
transglutaminase type 1 genes, respectively. Taken together, we showed that PPARb/d regulates epidermal maturation via
ANGPTL4-mediated signalling pathway.
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Introduction
Adult epidermis is a stratified self-renewing epithelium in which
keratinocytes in the basal and suprabasal layers cease to divide,
concomitant with their outward movement, giving rise to
differentiated cell layers of the spinous layer, granular layer and
the stratum corneum. A tightly regulated homeostatic balance of
epidermal cell proliferation and differentiation ensures proper
epidermal structure and function [1,2]. Transcriptional regulation
plays an important role in skin maturation and abundant
information is available on the various differentiation markers
expressed in the epidermis [2,3].
Nuclear hormone receptors, one of the largest known classes of
transcription factors, have been implicated in skin development
and maturation. Thyroid hormone, glucocorticoid, estrogen,
vitamin D and retinoid X receptors, among others, were reported
to either accelerate the maturation of the skin permeability barrier
or modulate the differentiation of the epidermis [4,5]. Of
particular interest is the role of peroxisome proliferator–activated
receptors (PPARs) b/d isoform in epidermal differentiation and
wound healing [6–10]. PPARb/d is an important regulator of
keratinocyte survival in the wounded epidermis and is involved in
cell adhesion and migration [11,12]. A novel homeostatic control
of keratinocyte proliferation was recently found, whereby PPARb/
d regulates IL-1 signalling in dermal fibroblasts [13]. In addition to
wound re-epithelialization, PPARb/d was also shown to stimulate
epidermal differentiation [7,10]. Our earlier results also confirmed
a cell-autonomous action of PPARb/d in human keratinocyte
differentiation [13]. However, the precise mechanism by which
PPARb/d modulates epidermal differentiation remains obscure.
The adipocytokine angiopoietin-like 4 (ANGPTL4) represents a
novel endocrine signal involved in the regulation of lipid and
glucose metabolism, especially under fasting conditions [14–16].
The hypertriglyceridemic effect of ANGPTL4 is attributable to
inhibition of lipoprotein lipase (LPL)-dependent very low density
lipoprotein lipolysis by conversion of LPL dimers to monomers
[17]. ANGPTL4 protects mice against the severe pro-inflamma-
tory effects of dietary saturated fat in mesenteric lymph nodes by
inhibiting macrophage LPL enzyme activity [18]. Podocyte-
specific transgenic overexpression of hyposialylated ANGPTL4
induces proteinuria in glucocorticoid-sensitive nephrotic syndrome
[19]. Recently, ANGPTL4 is shown to be important for cancer
cell survival, where it sustains an elevated pro-survival intracellular
O2
2:H2O2 ratio and confers anoikis resistance to tumor [20].
Effective cell-matrix communication is crucial for efficient wound
healing. Recently, PPARb/d was shown to modify the wound
microenvironment to coordinate cell-matrix communication by
the upregulation of ANGPTL4. During wound healing,
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e25377ANGPTL4 functions as a matricellular protein to coordinate cell-
matrix communications by modulating integrin-mediated signal-
ing pathway and intact matrix proteins availability which are
essential for keratinocyte migration [21,22]. Similar to PPARb/d,
the expression of ANGPTL4 remains elevated after complete
wound re-epithelialization. However, whether ANGPTL4 is
involved in post-healing epidermal differentiation remains un-
known. Herein, we showed that PPARb/d-mediated upregulation
of ANGPTL4 expression in human keratinocytes stimulates the
expression of protein kinase C (PKC) and activities of activator
protein-1 (AP-1) transcription factors to modulate epidermal
differentiation.
Results
PPARb/d modulates keratinocyte differentiation via an
indirect mechanism
Ligand-activated PPARb/d stimulates keratinocyte differentia-
tion by a cell-autonomous mechanism [13]. In the first instance,
we determine if PPARb/d directly regulates keratinocyte differ-
entiation. Human primary keratinocytes were treated with
100 nM of GW501516 (GW) in the presence or absence of
cycloheximide or actinomycin D. GW501516 is a selective PPAR
b/d agonist [23]. The mRNA levels of differentiation markers
cytokeratin 10, involucrin and transglutaminase 1 were increased
in GW-treated keratinocytes, consistent with previous observations
[10]. The increased mRNA levels induced by GW were abolished
in actinomycin- and cycloheximide-treated cells, suggesting that
ligand-activated PPARb/d required de novo gene transcription and
protein translation to stimulate keratinocytes differentiation. The
pro-differentiating effect of GW was absent in PPARb/d-deficient
(KPPARb/d) keratinocytes indicating that GW mediates its effect via
PPARb/d (Figure 1A). KPPARb/d cells were obtained as previously
described [13]. As expected, the mRNA level of ANGPTL4, a
PPARb/d target gene, was increased by GW treatment, and
abolished in actinomycin- but not cycloheximide-treated cells, as
previously observed [14,24].
ANGPTL4 deficiency results in impaired epidermal
differentiation
To examine if ANGPTL4 plays a role in epidermal differen-
tiation, we first examine the skin biopsies from ANGPTL4-null
(ANGPTL4
2/2) and wildtype (ANGPTL4
+/+) mice [25]. The
deficiency in ANGPTL4 resulted in thinner epidermis
(ANGPTL4
+/+ vs ANGPTL4
2/2: 32.5612.4 vs 21.964.6 mm,
p,0.01, n=8) (Figure 2A). Immunofluorescence (IF) staining
using differentiation markers, cytokeratin 10 and filaggrin showed
that ANGPTL4
2/2 had an impaired epidermal differentiation
when compared with ANGPTL4
+/+ (Figure 1B). Immunoblot
analysis using differentiation markers, cytokeratin 10 and trans-
glutaminase 1, further confirmed our findings (Figure 1B).
ANGPTL4
2/2 epidermis also showed more apoptotic (TUNEL-
positive) (ANGPTL4
+/+ vs ANGPTL4
2/2:4 61.7 vs 1263.4
labeled cells per microscopic field; p,0.01, n=8) and reduced
Ki67-positive proliferating cells as compared to the control
wildtype (ANGPTL4
+/+ vs ANGPTL4
2/2:1 5 61.1 vs 460.7;
p,0.01, n=8) (Figure 1B). These were further supported by
immunoblotting with cyclin D1 and PCNA as proliferation
markers, as well as with cleaved caspase 3 as an apoptotic marker
(Figure 1C). Lending additional support, our focused real-time
PCR gene expression analysis comparing the skin biopsies from
ANGPTL4
+/+ and ANGPTL4
2/2 mice confirmed a consistent
down-regulation of numerous genes involved in the differentiation
and proliferation of ANGPTL4
2/2 skin (Table S1).
To further strengthen our findings, we performed similar
analysis using organotypic skin culture (OTC) which closely
mimics epidermal regeneration [13,26]. We first suppressed
endogenous ANGPTL4 expression using a lentivirus-mediated
ANGPTL4 siRNA in the primary human keratinocytes as
previously described [21,22]. The ANGPTL4 expression level in
ANGPTL4-knockdown keratinocytes (KANGPTL4) was reduced by
90% compared with scrambled control-siRNA keratinocytes
(KCTRL). No detectable change in the mRNA level of angiopoie-
tin-like 3 (ANGPTL3), a member of the angiopoietin-like protein
family that has the highest sequence similarity to ANGPTL4,
indicating the specificity of the knockdown (Figure 2A). The
specificity of anti-ANGPTL4 antibody was previously verified
[21].
In OTC, either KCTRL or KANGPTL4 keratinocytes were seeded
on a dermal fibroblast-embedded collagen matrix and cultured at
air-exposed interface to induce stratification and differentiation.
Consistent with the above findings from the mice skin biopsies,
haematoxylin and eosin stain revealed that the epidermis was
thinner in KANGPTL4 than KCTRL (KANGPTL4 vs KCTRL:
248.7625.1 vs 328.9627.4 mm, p,0.01, n=6) (Figure 2B). IF
staining and immunoblot analysis using differentiation markers
cytokeratin 10, filaggrin and transglutaminase 1 showed that
KANGPTL4 OTCs had an impaired epidermal differentiation when
compared with KCTRL (Figure 2B & C). KANGPTL4 OTCs also
showed more apoptotic (TUNEL-positive) (KANGPTL4 vs KCTRL:
5362.7 vs 1862.5 labeled cells per microscopic field; p,0.01,
n=6) and reduced Ki67-positive proliferating cells as compared to
KCTRL OTCs (KANGPTL4 vs KCTRL:1 8 62.9 vs 3168.1; p,0.01,
n=6) (Figure 2B). These were further supported by immunoblot-
ting with cyclin D1 and PCNA as proliferation markers, as well as
with cleaved caspase 3 as an apoptotic marker (Figure 2C).
Altogether, these results suggest that ANGPTL4 modulates
epidermal differentiation.
ANGPTL4 protein induces keratinocyte differentiation
ANGPTL4 is a direct transcriptional target gene of PPARb/d in
murine and human keratinocytes. As a novel matricellular protein,
ANGPTL4 may play an important role in cellular proliferation and
differentiation [21,22]. To investigate if ANGPTL4 is required for
PPARb/d-mediated keratinocyte differentiation, we first examine
the expression of differentiation markers on GW-treated KCTRL,
KPPARb/d and KANGPTL4 keratinocytes. Consistent with our above
findings, GW-activated PPARb/d induced keratinocyte differenti-
ation as evidenced by the increased expression of transglutaminase
type I, involucrin and cytokeratin 10 (Figure 3A), which was
diminished either upon co-treatment with selective PPARb/d
antagonist GSK0660 [27] or in KPPARb/d, as well as in KANGPTL4
(Figure 3A). Notably, the differentiation potential of KPPARb/d was
restored byexogenousrecombinantANGPTL4protein(Figure3A).
To further strengthen our finding, we subjected OTCs to various
indicated treatments and examined epidermal differentiation by
immunostaining. Comparing KPPARb/d and KCTRL-derived OTCs,
our results confirmed that GW mediated its pro-differentiation
effect via PPARb/d (Figure 3B, upper panel). ANGPTL4-deficient
keratinocytes also exhibited impaired epidermal differentiation
regardless of GW treatment (Figure 3B, lower panel). Epidermal
differentiation was also attenuated upon co-treatment with
neutralizing monoclonal anti-ANGPTL4 antibodies (mAb11F6C4)
(Figure 3B, lower panel), which was shown previously to block the
interaction of ANGPTL4 with either specific integrins or extracel-
lular matrix proteins [20–22]. Consistent with the pro-differentia-
tion role of ANGPTL4, exogenous recombinant ANGPTL4
stimulated epidermal differentiation in KANGPTL4-derived OTCs.
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PPARb/d-mediated keratinocyte differentiation.
ANGPTL4 modulates PKC and AP-1 dependent signaling
pathways
The activation of PKC and various members of transcriptional
factor AP-1 are important for the expression of different
keratinocyte differentiation markers [28,29]. Differentiation-pro-
moting agents have been shown to regulate the expression of
differentiation marker genes via activation of PKC-dependent
signaling pathway that targets AP-1 proteins. ANGPTL4 interacts
with specific integrins and their cognate ligands to activate
integrin-mediated signaling [20–22]. To gain more insight into
ANGPTL4-mediated signaling pathways for keratinocyte differ-
entiation, we performed immunoblot analysis of indicated
intracellular signaling mediators. Consistent with the notion of
integrin activation, the expression of phosphorylated FAK was
reduced in KANGPTL4 as compared with KCTRL (Figure 4A). Our
immunoblot also showed an attenuated expression of classical and
novel PKC isoforms, namely PKCa, d, e and g in KANGPTL4,
compared with KCTRL (Figure 4A). We also detected a diminished
level of phosphorylated ERK-1/2 in KANGPTL4, which has been
shown to down-regulate PKCd [30]. KANGPTL4 also exhibited
Figure 1. ANGPTL4 deficiency in mice impairs epidermal differentiation. (A) PPARb/d regulates keratinocyte differentiation requires de novo
transcription and translation. Relative fold change in mRNA levels of cytokeratin 10, involucrin and transglutaminase type 1 in control (KCTRL) and
PPARb/d-knockdown (KPPARb/d) human keratinocytes treated with either DMSO vehicle or PPARb/d agonist GW501516 (GW, 100 nM), in the absence
or presence of RNA synthesis (actinomycin D, Act-D) or protein synthesis (cycloheximide, CHX) inhibitors as determined by quantitative real-time PCR.
Act-D and CHX treatment alone did not affect the transcript level. Ribosomal protein L27 was used as a normalizing reference gene. Values are mean
6 SEM of three independent experiments. (B) Haematoxylin and eosin (H&E) and immunofluorescence staining of skin biopsies from wildtype
(ANGPTL4
+/+) and ANGPTL4-knockout (ANGPTL4
2/2) mice. Early (cytokeratin 10, CK10), late (fillaggrin, FIL) differentiation markers, proliferating (Ki67)
and apoptotic (TUNEL) cells were identified using indicated antibodies or assay. White dotted lines indicated epidermis-dermis junctions. Sections
were counterstained with DAPI (blue). Scale bars represent 40 mm. (C) Representative immunoblot of early differentiation (cytokeratin 10, CK10),
terminal differentiation (transglutaminase type I, Tgase 1), proliferation (PCNA and cyclin D1), and apoptosis (cleaved caspase 3) markers in
ANGPTL4+/+ and ANGPTL42/2 skin biopsies. Immunoblot data are from three independent experiments performed in duplicate. b-tubulin serves as
a loading and transfer control.
doi:10.1371/journal.pone.0025377.g001
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mediated signal transduction (Figure 4A). The expression of PKCm
appeared slightly reduced in KANGPTL4 when compared with with
KCTRL, albeit not statistically significant (Figure 4A). The
dysregulation of PKCs would have an influence on the activation
of AP-1 proteins and subsequently keratinocyte differentiation
[26,28]. Indeed, our immunoblot analysis showed reduced
phosphorylated i.e. activated c-JUN and JUNB (Figure 4A). To
examine if ANGPTL4 has a direct effect on the expression of these
signaling proteins, we examined their mRNA levels in KANGPTL4
treated with recombinant ANGPTL4 in the presence of either
actinomycin D or cycloheximide. The increased mRNA levels of
PKCa and PKCd induced by ANGPTL4 were abolished in
actinomycin D- but not cycloheximide-treated cells, suggesting a
transcriptional regulatory mechanism. Interestingly, no difference
in c-JUN mRNA level was detected in all tested conditions,
indicating a post-translation mechanism, most likely phosphory-
lation (Figure 4B). Similarly changes in total or phosphorylated
protein expression level was also observed in the skin biopsies of
ANGPTL4
+/+ and ANGPTL4
2/2 mice (Figure 4C).
The human ANGPTL4 gene is transcriptionally regulated by
PPARb/d and HIFa. Indeed, functional PPAR response elements
and HIF binding site have been identified [24,32]. It was also
reported that phorbol ester regulates ANGPTL4 expression in
human smooth muscle cells [33]. In addition, several putative AP-
1 binding sites were observed on the human ANGPTL4 promoter
[33]. Thus, we question if AP-1 can regulates ANGPTL4 gene
transcription in keratinocytes. To this end, we examine the
expression level of ANGPTL4 mRNA in keratinocytes transfected
with expression vector encoding for either MKK&-JNK or
TAM67, a dominant negative AP-1. The expression of MKK7-
JNK fusion proteins led to constitutive activation of JNK through
intramolecular phosphorylation by MKK7, and increases AP-1
activity [28,34]. As positive control, the level of transglutaminase
type 1 mRNA was used. As expected, keratinocytes transfected
with expression vector for MKK7-JNK showed a 3.5-fold increase
in the mRNA level of transglutaminase type 1, which was
abolished when cells were co-transfected with TAM67 (Figure 4D).
No significant change in ANGPTL4 mRNA was observed in
keratinocytes under all examined conditions, indicating that its
Figure 2. Organotypic skin coculture (OTC) of ANGPTL4-deficient human primary keratinocytes displayed impaired epidermal
differentiation. (A) Relative mRNA and/or protein levels of ANGPTL4 and ANGPTL3 in human primary keratinocytes transduced with either
scrambled control (KCTRL) or ANGPTL4 siRNA (KANGPTL4). Values below immunoblot bands represent the mean fold differences in protein expression
level when compared with KCTRL from 3 independent experiments. (B) Haematoxylin and eosin (H&E) and immunofluorescence staining of OTC
sections constructed with either control (KCTRL) or ANGPTL4-knockdown (KANGPTL4) human keratinocytes. Late (fillaggrin, FIL) differentiation markers,
proliferating (Ki67) and apoptotic (TUNEL) cells were identified using indicated antibodies or assay. White dotted lines indicated epidermis-dermis
junctions. Sections were counterstained with DAPI (blue). Scale bars represent 40 mm. (C) Representative immunoblot of early epidermal
differentiation (cytokeratin 10, CK10), terminal differentiation (transglutaminase type I, Tgase 1), proliferation (PCNA and cyclin D1), and apoptosis
(cleaved caspase 3) markers in isolated epidermis of indicated OTCs. All immunoblot data are from three independent experiments performed in
duplicate. b-tubulin serves as a loading and transfer control.
doi:10.1371/journal.pone.0025377.g002
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(Figure 4D).
ANGPTL4 increases activated AP-1 binding on the
promoters of human involucrin and transglutaminase
type 1 gene
Finally, to determine whether ANGPTL4-stimulated AP-1
activation was associated with changes in the transcription
regulation of AP-1 dependent differentiation protein markers, we
performed chromatin immunoprecipitation (ChIP) using either
phospho-c-JUN or JUNB. Our ChIP showed that phospho-JUNB
specifically bound to the AP-1 responsive elements in the promoter
of human involucrin gene in KCTRL but not in KANGPTL4.
Similarly, ChIP using phospho-c-JUN antibody showed that
phosphorylated c-JUN was bound to the AP-1 responsive elements
in promoter of human transglutaminase type 1 gene in KANGPTL4
treated with recombinant ANGPTL4, when compared with
vehicle (PBS) (Figure 4E). No immunoprecipitation and amplifi-
cation were seen with pre-immune IgG and with a control
sequence upstream of the AP-1 element in the promoters of
transglutaminase type 1 and involucrin gene (Figure 4E). Alto-
Figure 3. PPARb/d modulates epidermal differentiation via ANGPTL4. (A) Immunoblot analysis of early (cytokeratin 10, CK 10), late
(involucrin) and terminal (transglutaminase type I, Tgase 1) epidermal differentiation markers in KCTRL,K PPARb/d or KANGPTL4 keratinocytes. (B)
Immunofluorescence staining of late epidermal differentiation (involucrin, INV) and proliferation (Ki67) markers of either KCTRL-, KPPARb/d-o rK ANGPTL4-
dervied OTC sections, subjected to indicated treatments. PPARb/d agonist GW501516 (GW, 100 nM), PPARb/d antagonist GSK0660 (GSK, 0.5 mm),
recombinant ANGPTL4 (rec. ANGPTL4, 6 mg/ml) and blocking ANGPTL4 monoclonal antibody (mAb11F6C4, 6 mg/ml). mAb11F6C4 targets the
C-terminal fibrinogen-like domain of ANGPTL4 and has been shown to block ANGPTL4 interaction with integrin b1/b5. Immunoblot data are from
three independent experiments performed in duplicate. b-tubulin serves as a loading and transfer control. White dotted lines indicated epidermis-
dermis junctions. Sections were counterstained with DAPI (blue). Scale bars represent 40 mm.
doi:10.1371/journal.pone.0025377.g003
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25377Figure 4. ANGPTL4 modulates the expression of PKCs and activities of AP-1. (A and C) Representative immunoblot analysis of indicated
proteins from (A) epidermis of KCTRL- and KANGPTL4-derived OTCs or (C) skin biopsies of ANGPTL4
+/+ and ANGPPTL4
2/2 mice. Values below
immunoblot bands represent the mean fold differences in protein expression levels when compared with either KCTRL (for A) or ANGPTL4
+/+ (for C),
which was assigned the value one, from 3 independent experiments. b-tubulin serves as a loading and transfer control. (B) Relative fold change in
mRNA levels of c-JUN, PKCa and PKCd in control (KCTRL) human keratinocytes treated with either DMSO vehicle or recombinant ANGPTL4 (6 mg/ml), in
the absence or presence of RNA synthesis (actinomycin D, Act-D) or protein synthesis (cycloheximide, CHX) inhibitors as determined by quantitative
real-time PCR. Act-D and CHX treatment alone did not affect the transcript level. (D) Relative fold change in mRNA levels of ANGPTL4 and
transglutaminase type I in human keratinocytes transiently transfected with expression vectors encoding for either MMK7-JNK or TAM67. Empty
expression vector was used a scontrol. Ribosomal protein L27 was used as a normalizing reference gene. Values are mean 6 SEM of three
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mediates keratinocyte differentiation, at least through a mecha-
nism that involves the transcriptional regulation of ANGPTL4 and
subsequent activation of PKCs and AP-1 transcription factors.
Discussion
Epidermal maturation involves keratinocyte differentiation
which is crucial to protect the organism from dehydration and
to defense against microbial, mechanical, chemical and UV
aggression. Here we provide a mechanism for the role of
ANGPTL4, PPARb/d target gene, in epidermal differentiation
via AP-1-dependent signaling pathways. We noted that the pro-
differentiating effect of ligand-activated PPARb/d is cell-autono-
mous and mediated by an indirect mechanism. This is consistent
with earlier studies using organotypic skin coculture [13] and that
the increase in the expression of differentiation-related proteins
was a late events, appearing only after 48 h of treatment [10].
Careful analysis of organotypic skin cocultures constructed using
PPARb/d and ANGPTL4-deficient human keratinocytes, immu-
noblotting, as well as reconstitution and immuno-depletion
experiments revealed that the autonomous regulation of epidermal
differentiation by PPARb/d is mediated via ANGPTL4 and its
intracellular modulation through an integrin-mediated signaling.
Our observation suggested that ANGPTL4 stimulated the increase
activation of c-JUN and JUNB, while it transcriptionally regulated
the expression of PKCs. Indeed, chromatin immunoprecipitation
further confirmed that differentiation markers like transglutamin-
ase 1 and involucrin were induced by ligand activated-PPARb/d
and ANGPTL4, associated with increased AP-1 binding to the
cognate promoter. Immunoblotting analysis also showed a
decrease in the expression of classical and novel PKC isoforms
in ANGPTL4-deficient epidermis. The role of PKCs in the
epidermal differentiation is well-established [28]. Both the
PPARb/d- and ANGPTL4- knockout mice did not display any
obvious skin abnormalities at normal situation. However, these
mutant mice exhibited impaired wound repair and displayed
altered epidermal differentiation, indicating that their role is
context-dependent such as wound healing. This is also consistent
with the role of ANGPTL4 as a matricellular protein, which has a
distinguishing characteristic that it is expressed at high levels in
response to injury [35].
Early studies have provided strong evidence for the involve-
ment of PPARb/d in the different phases of wound healing
process [8,9]. The expression of PPARb/d is upregulated in adult
epidermis by inflammatory stimuli during skin injury, which also
provokes keratinocyte activation [6,7]. Further studies showed
that the activation of PPARb/d conferred an anti-apoptotic effect
on the keratinocytes in vivo, hence protecting them from cytokine-
induced apoptosis during the inflammatory phase of wound
repair, thereby maintaining a sufficient number of viable
migratory keratinocytes. PPARb/d activity also amplifies the
response of keratinocytes to a chemotactic signal, promotes
integrin recycling in wound keratinocytes and stimulates the
production of ANGPTL4 in wound epithelia to modulate the
wound microenvironment and thereby favors cell migration for
re-epithelialization phase of the wound healing process [7,11,22].
Our result herein provides new insights into the mechanism by
which PPARb/d-mediated ANGPTL4 to regulate PKCs and AP-
1 transcription factor for epidermal differentiation, suggest that it
may also be important for the maturation of the epidermis
consequently its functional integrity in the remodeling phase of
wound healing. Our study also provides a novel role of
ANGPTL4 that will be of value to future investigation of
transcriptional networks involved in complex epithelia develop-
ment and differentiation.
The role of ANGPTL4 in the differentiation of other cell types
remains unclear, although several evidences suggested that
ANGPTL4 may be involved in or associated with adipose
differentiation, endothelial cell growth and tubule formation.
Hormone-dependent adipocyte differentiation coincided with a
dramatic early induction of the ANGPTL4 transcript. The
ANGPTL4 gene was expressed in mouse 3T3-L1 adipocytes
before and after differentiation, the level increasing post-
differentiation [16,24,36]. However, the in vivo role of
ANGPTL4 in adipocyte maturation is complicated as transgenic
ANGPTL4 or knockout mice showed that the maintenance of
normal fat mass was a result from compensatory metabolic
changes in adipose triglyceride metabolism [25]. It was reported
that phornol ester and PDGFa induced the mRNA and 4 in
several cell types of the lung. They revealed that this induction
was mediated via PKC, ERK and JNK pathways. Importantly,
they proposed that this induction of ANGPTL4 through the
activation of PKC may play an important role in the regulation of
airway remodeling and lipid homeostasis [33]. The role of
ANGPTL4 on tubule formation of endothelial cells remains
controversial. In vitro experiments using purified recombinant
ANGPTL4 protein revealed that ANGPTL4 markedly inhibited
the proliferation, chemotaxis and tubule formation of endothelial
cells [37,38]. However, other reports found that ANGPTL4
stimulated endothelial cell growth and tubule formation partic-
ularly in neovascularization of adipose tissue to support increased
adipocyte number [39]. In support, we also showed reduced
angiogenesis in ANGPTL4
2/2 mice during skin wound repair
when compared with ANGPTL4
+/+ mice [21,22]. Clearly, these
observations justify further investigations on the role of
ANGPTL4 in differentiation of other cell types.
Materials and Methods
Reagents and antibodies
Antibodies used: Ki67, cytokeratin 10 (CK10) and filaggrin
(NovoCastra); Alexa488- or Alexa594-conjugated secondary
antibodies (Molecular Probes); b-tubulin, cyclin D1, PCNA,
RACK-1, transglutaminase 1 (Tgase 1), ERK-1, p(T202/Y204)-
ERK1/ERK2 and HRP-conjugated secondary antibodies (Santa
Cruz Biotechnology); PKC isotypes (BD Biosciences); FAK,
caspase 3 and cleaved caspase 3 (Cell Signaling); polyclonal
antibodies against the C-terminal fibrinogen-like region mouse of
ANGPTL4 were produced in-house. Rat tail collagen type I was
obtained from BD Biosciences. Primary neonatal human fibro-
blasts and keratinocytes were obtained from Invitrogen. Otherwise
stated all chemicals were from Sigma-Aldrich.
independent experiments. (E) Chromatin immunoprecipitations were done either with vehicle (PBS)- and recombinant ANGPTL4-treated KANGPTL4 or
with KCTRL and KANGPTL4 keratinocytes using pre-immune IgG (pre), antibody against phospho-cJUN and phospho-JUNB (Ab). The AP-1 binding site in
the human transglutaminase type 1 and involucrin promoter region were immunoprecipitated and specifically amplified using phospho-cJUN and
phospho-JUNB, respectively. No amplified signal was obtained in vehicle-treated KANGPTL4,K ANGPTL4 or using pre-immune IgG. A control region
upstream of the AP-1 binding site served as negative control. Aliquots of the chromatin were also analyzed before immunoprecipitation (input). M:
100-bp DNA marker.
doi:10.1371/journal.pone.0025377.g004
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Primary human keratinocytes and fibroblasts were routinely
maintained in defined keratinocyte growth medium (EpiLife;
Invitrogen) and medium 106, respectively, as described by the
manufacturer. OTCs were performed as previously described
[13].
Immunofluorescence
Tissues or OTCs were fixed with 4% paraformaldehyde in PBS
for 2 h at 25uC. The fixed OTCs were washed twice with PBS and
embedded in Tissue-Tek OCT freezing compound medium
(Sakura). 10 mm cryostat tissue sections were mounted on Super-
Frost Plus slides (Menzel-Glaser). The sections were processed for
immunofluorescence as previously described [40]. The apoptotic
keratinocytes were detected using the TUNEL assay according to
the manufacturer’s protocol (Roche). As positive control for the
TUNEL assay, the section was pretreated with DNase I. The slides
were mounted with antifade reagent (ProLong Gold; Invitrogen)
with DAPI. Images were taken using a Zeiss LSM 710 confocal
microscope with a 406objective and ZEN 2009 software.
Animal Experiment. Pure-bred wild type (ANGPTL4+/+)
and ANGPTL4-knockout (ANGPTL42/2) mice on a C57Bl/6
background were used [25]. All mice used in this study were
individually caged, house in a temperature-controlled room (23uC)
on a 10-h dark/14-h light cycle, and fed with the standard mouse
chow diet. A full thickness mid-dorsal skin biopsy (0.5-cm
2) was
excised from 8-week old male mice. The biopsy was either
processed for immunofluorescence staining or snap frozen in liquid
nitrogen for protein extraction and subsequent immunoblot
analysis. Animal experiments were approved by the University
Institutional Animal Care and Use Committee (ARF-SBS/NIE-A-
0093, -0078, and -004) and Biological Safety Committee (BPN-
0004-2011-SBS). Hematoxylin and eosin (H&E) stained images
and histomorphometric measurements were taken using using
MIRAX MIDI with Plan-Apochormatic 206/0.8 objectives using
MIRAX Scan software (Carl Zeiss). Epidermal thickness was
obtained from three independent skin biopsies using TissueQuest
software (TissueGnostics GmbH) [21].
Knockdown of ANGPTL4
siRNA against human ANGPTL4 and scrambled sequence as
control were subcloned into the pFIV-H1/U6-puro siRNA
lentivirus system. The correct pFIV siRNA construct was verified
by sequencing using H1 primer. The sequence of the siRNAs was
as given in Table S2. Pseudoviruses were purified and transduced
as described [13,40]. Transient suppression of endogenous
ANGPTL4 expression in human keratinocytes was performed
using either siGLO control or ON-TARGETplus SMARTpool
ANGPTL4 siRNA (Dharmacon; L-007807-00) by means of
DharmaFECT1.
Transient Transfection
Human keratinocytes were transfected with cDNA encoding for
MKK7-JNK or co-transfected with TAM67 as previously
described. The expression levels of ANGPTL4 and transgluta-
minase type 1 were determined by real-time PCR. The expression
vectors for MKK7-JNK and TAM67 were kind gift from R.J.
Davis (University of Massachusetts Medical School, Worcester)
and D.J. Templeton (University of Virginia Medical School,
Charlottesville).
Total RNA extraction and Real-time PCR
Total RNA was purified from homogenized tissues and OTCs
using RNAeasy kit (Qiagen). Five mg total RNA was reverse
transcribed with oligo-dT primers and qPCR was performed as
previously described [21,22]. Melt curve analysis was included to
assure that only one PCR product was formed. Primers were
designed to generate a PCR amplification product of 100–250 bp.
Only primer pairs yielding unique amplification products without
primer dimer formation were subsequently used for real-time PCR
assays. Expression was related to the control gene ribosomal
protein L27 (L27), which did not change under any of the
experimental conditions studied. Primer sequences for real-time
PCR are provided in Table S3.
Chromatin immunoprecipitation (ChIP)
ChIP was performed as previously described [40], except that
anti-p(Ser63)-c-JUN and anti-p(S79)JUNB antibodies were used.
The sequence of the ChIP primers was as given in Table S1.
Immunoblot analysis
Epidermis was physically separated from OTC after a 20-min
treatment with dispase. Fibroblasts embedded in collagen were
isolated after collagenase treatment. For Western blotting, protein
extracts were made in ice-cold lysis buffer (20 mM Na2H2PO4,
250 mM NaCl, 1% Triton X-100, and 0.1% SDS). Equal
amounts of protein extracts (50 mg) were resolved by SDS-PAGE
and electrotransferred onto PVDF membranes. Membranes were
processed as described by the manufacturer of antibodies, and
proteins were detected by chemiluminescence (Millipore). Coo-
massie blue-stained membrane or b-tubulin was used to check for
equal loading and transfer. Membrane was also stripped and
reprobed with another antibody as described [40,41].
Statistical analysis
Statistical analyses were performed using two-tailed Mann-
Whitney tests with SPSS software. All statistical tests were two-
sided. p value of #0.05 is considered significant.
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